Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dexamethasone vs placebo to reduce acute phase reaction after first zoledronic acid infusion
ACTRN12621000415808Phase 4Completed
- Sponsor
- Bone & Joint Research Group
- Start
- May 2021
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial in osteoporosis and Paget's disease of bone comparing Dexamethasone + zoledronic acid with Placebo + zoledronic acid (2 arms). Primary endpoint: Between-group difference in temperature change from baseline. Started May 2021; status: completed.
02
Drugs
dexamethasone
03
Conditions
osteoporosisPaget's disease of bone
Beyond the preview
Go deeper on ACTRN12621000415808.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12621000415808.